Pemetrexed disodium

Mfr.No.	T0189L
Description	Pemetrexed disodium (LY-231514) is a parenterally administered folate antagonist and antineoplastic agent, used in the treatment of non-small cell lung cancer and malignant mesothelioma. Pemetrexed disodium therapy has been associated with moderate rates of serum enzyme elevations during therapy, but has not been convincingly linked to instances of acute, clinically apparent liver injury.
Alternative Names	LY231514 disodium
Molecular Formula	C20H19N5Na2O6
Signaling Pathways	Metabolism, DNA Damage/DNA Repair, Apoptosis, Cell Cycle/Checkpoint, Autophagy
Smiles	(Na+).(Na+).Nc1nc2(nH)cc(CCc3ccc(cc3)C(=O)N(CH)(CCC((O-))=O)C((O-))=O)c2c(=O)(nH)1
Cas Number	150399-23-8
Molecular Weight	471.37
Target	Apoptosis, DNA/RNA Synthesis, DHFR, Antifolate, Autophagy

Have you used this product?

SKU	Supplier No.	Size	Your price
BHB20400170	T0189L	1 g	$218	Add to Cart
BHB20400170	T0189L	1 mL	$39	Add to Cart
BHB20400170	T0189L	25 mg	$37	Add to Cart
BHB20400170	T0189L	50 mg	$51	Add to Cart
BHB20400170	T0189L	100 mg	$66	Add to Cart
BHB20400170	T0189L	200 mg	$92	Add to Cart
BHB20400170	T0189L	500 mg	$148	Add to Cart